Effect of denosumab versus zoledronic acid in preventing skeletal-related events in patients with bone metastases by baseline characteristics

  1. Lipton, A.
  2. Fizazi, K.
  3. Stopeck, A.T.
  4. Henry, D.H.
  5. Smith, M.R.
  6. Shore, N.
  7. Martin, M.
  8. Vadhan-Raj, S.
  9. Brown, J.E.
  10. Richardson, G.E.
  11. Saad, F.
  12. Yardley, D.A.
  13. Zhou, K.
  14. Balakumaran, A.
  15. Braun, A.
Revista:
European Journal of Cancer

ISSN: 1879-0852 0959-8049

Ano de publicación: 2016

Volume: 53

Páxinas: 75-83

Tipo: Artigo

DOI: 10.1016/J.EJCA.2015.09.011 GOOGLE SCHOLAR lock_openAcceso aberto editor

Obxectivos de Desenvolvemento Sustentable